Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:4345-03-3
Molecular Formula:C33H54O5
Alias
More Information
D-Alpha-Tocopherol Succinate; Alpha-Tocopheryl Succinate; Alpha-Tocopherol Succinate; d-α Tocopheryl acid Succinate; d-Alpha-Tocopherol acid Succinate; Alpha Tocopheryl acid Succinate; D-A-Tocopherol Acid Succinate; (+)-Alpha-Tocopherol Acid Succinate; Vitamin E Succinate(Tocopherol Succinate)(P) Printback; α-Tocopheryl Succinate; Trimethoxy(Octadecyl)Silane
Brief Introduction
This product is used for pressing multi-dimensional tablets, filling hard capsules, additives for high-grade health food and raw materials for high-grade cosmetics.
Suppliers
View More Vendors (5） >
Tocopherol acetate content: 1185IU
/
Food Grade
25kg
/
Fibre Drum
CAS:112809-51-5
Molecular Formula:C17H11N5
Alias
More Information
Letrozoleusp28; Cgs-20267; Letrazole; Letrozolex; Lelrozol; 1-[Bis(4-Cyanophenyl)Methyl]-1,2,4-Triazole; 4,4'-(1H-1,2,4-Triazol-1-Ylmethylene)Dibenzonitrile; Femara; 4,4'-(1H-1,2,4-Triazol-1-Ylmethylene)bis(Benzonitrile); UNII-7LKK855W8I; 4,4'-((1h-1,2,4-Triazol-1-yl)Methylene)Dibenzonitrile; Letrozol; Letoval; 4,4'-(1H-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile; Femera; [14C]-Letrozole; 4-[(4-Cyanophenyl)-(1,2,4-Triazol-1-yl)Methyl]Benzonitrile
Brief Introduction
Letrozole is a new generation of highly selective aromatase inhibitor, which is a synthetic benzyltriazole derivative. By inhibiting aromatase, letrozole can reduce the level of estrogen, so as to eliminate the stimulating effect of estrogen on tumor growth. The in vivo activity is 150-250 times stronger than that of the first generation aromatase inhibitor amlumide. Because of its high selectivity, it does not affect the function of glucocorticoid, mineralocorticoid and thyroid. High dose use has no inhibitory effect on the secretion of adrenal corticosteroids, so it has a high therapeutic index. Preclinical studies have shown that letrozole has no potential toxicity, mutagenic and carcinogenic effects on various systems and target organs of the body, and has less toxic and side effects, good tolerance. Compared with other aromatase inhibitors and anti estrogen drugs, letrozole has stronger anti-tumor effect. It is suitable for the treatment of patients with advanced breast cancer who are not effective in the treatment of estrogen and early treatment of breast cancer.
Suppliers
View More Vendors (5） >
Alias
More Information
Phthalazinone; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-Dihydro-4-Oxo-1-Phthalazinyl)Methyl]-2-; 4-(3-(4-(Cyclopropanecarbonyl)Piperazine-1-Carbonyl)-4-Fluorobenzyl)Phthalazin-1(2H)-One
Brief Introduction
Ola Pani is a chemotherapeutic agent for the treatment of recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and previous history of chemotherapy. Olapani is sold under the lynparza brand in the form of oral tablets and was originally designated as maintenance therapy or monotherapy for adult patients with recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.
Suppliers
View More Vendors (4） >
CAS:120511-73-1
Molecular Formula:C17H19N5
Alias
More Information
Ici-D-1033; Zd-1033; Anastrol; 1,3-Benzenediacetonitrile; Anastrazole; 2,2'-(5-((1H-1,2,4-Triazol-1-Yl)Methyl)-1,3-Phenylene)Bis(2-Methylpropanenitrile); 4-Triazol-1-Ylmethyl)-1; Anastrolozole; Anatrozole; Anastrozol; Arimidex; 1-[3,5-Di-(1-Methyl-1-Cyano)-Ethyl]-Benzyl-1,2,4-Triazole; α,α,α’,α'-Tetramethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-1,3-Benzenediacetonitrile; 2-[3-(2-Cyanopropan-2-Yl)-5-(1,2,4-Triazol-1-Ylmethyl)Phenyl]-2-Methylpropanenitrile; α1,α1,α3,α3-Tetramethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-1,3-Benzenediacetonitrile
Brief Introduction
Anastrozole is a potent selective three azole aromatase inhibitor, which inhibits the cytochrome P-450 dependent aromatase and thus blocks the biosynthesis of estrogen. Estrogen is a major factor in stimulating the growth of breast cancer cells. Letrozole is suitable for postmenopausal women with advanced breast cancer, and is used for second-line treatment after the failure of anti estrogen therapy.
Suppliers
View More Vendors (4） >
CP/USP
/
Pharm Grade
25kg
/
Fibre Drum
CAS:129453-61-8
Molecular Formula:C32H47F5O3S
Alias
More Information
Faslodex (Trade Name); (7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-Pentafluoropentylsulfinyl)Nonyl]-6,7,8,9,11,12,14,15,16,17-Decahydrocyclopenta[A]Phenanthrene-3,17-Diol; (7A,17B)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]Estra-1,3,5(10)-Triene-3,17-Diol; 7A,17B-[9[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]Estra-1,3,5(10)-Triene-3,17-Diol; (7Alpha,17Beta)-Nonyl); Estra-1,3,5(10)-Triene-3,17-Diol,7-(9-((4,4,5,5,5-Pentafluoropentyl)Sulfinyl); 7-[9-[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]- (7α,17β)-Estra-1,3,5(10)-Triene-3,17-Diol
Brief Introduction
Fluticasone is an intramuscular injection developed by AstraZeneca. It was approved by the food and Drug Administration in April 2002 to treat estrogen receptor positive metastatic breast cancer in postmenopausal women whose disease is still deteriorating after anti estrogen therapy. Many breast cancer cells have estrogen receptor (ER), estrogen can stimulate the growth of such tumors. Fluvestrant is a "pure" estrogen receptor antagonist without partial estrogen like agonistic effect. It inhibits estrogen signal pathway by binding, blocking and down regulating er. It can competitively bind with ER. Its affinity with Er is close to estrogen, 100 times that of tamoxifen. It is the only anti estrogen drug that can be widely used in clinic after tamoxifen fails, Because the drug is endocrine therapy and will not cause common adverse reactions of chemotherapy, it has good patient compliance.
Suppliers
View More Vendors (4） >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!